HR1021LRB102 29752 LAW 41817 r


2    WHEREAS, Cardiovascular disease (CVD) is the leading cause
3of death in the United States, and African Americans have the
4highest overall mortality rate from coronary heart disease
5(CHD) of any ethnic group in the United States, particularly
6in out-of-hospital deaths and at especially younger ages; and
7    WHEREAS, According to the U.S. Census Bureau,
8approximately 21 million patients have been diagnosed with
9atherosclerotic cardiovascular disease (ASCVD) in the United
10States and are at risk of experiencing a cardiovascular event;
12    WHEREAS, The Mayo Clinic states that ASCVD is linked to
13the build-up of cholesterol in the arteries and the risk of
14associated events can be modified by lowering low-density
15lipoprotein cholesterol (LDL-C); and
16    WHEREAS, In 2016, nearly 70 million adults in the United
17States had higher than recommended LDL-C levels; and
18    WHEREAS, Approximately 43.1 million people in the United
19States are currently being treated with lipid-lowering
20therapies to manage cardiovascular risk; and



HR1021- 2 -LRB102 29752 LAW 41817 r

1    WHEREAS, Only 20% of people with ASCVD who are taking
2statins, one of the leading lipid-lowering therapies, actually
3achieve healthy levels of LDL-C; and
4    WHEREAS, The American Heart Association has indicated the
5total direct and indirect cost of ASCVD in the U.S. was $555
6billion in 2016 with it being projected to climb to $1.1
7trillion by 2035; and
8    WHEREAS, In Illinois, 776,900 adults have been told by a
9health professional that they had angina, a stroke, a heart
10attack, or coronary heart disease, which are some of the
11manifestations of ASCVD; 363,500 adults have reported
12experiencing a heart attack in their lifetime and 293,300
13adults have reported experiencing a stroke in their lifetime;
1413,484 people had ASCVD as an underlying cause of death; and
15    WHEREAS, Illinois spends an estimated $4.59 billion
16dollars on direct medical expenses for ASCVD care each year;
17therefore, be it
20we urge state agencies to expand comprehensive cardiovascular
21screening programs to allow for earlier identification of
22patients at risk of cardiovascular events; and be it further



HR1021- 3 -LRB102 29752 LAW 41817 r

1    RESOLVED, That we urge state agencies to explore ways to
2collaborate with federal and national agencies and
3organizations to establish or expand comprehensive
4cardiovascular screening programs; and be it further
5    RESOLVED, That we urge an update of the State's
6cardiovascular plan to accelerate quality improvements in the
7care rendered to these patients such that screening,
8treatment, monitoring, and improved health outcomes are
9achieved; and be it further
10    RESOLVED, That we support the creation of policies to
11decrease the rising number of deaths of Americans as a result
12of ASCVD; and be it further
13    RESOLVED, That suitable copies be delivered to the
14Governor, the Lieutenant Governor, the Director of the
15Department of Public Health, the Director of the Department of
16Healthcare and Family Services, and the Secretary of the
17Department of Human Services.